Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.
One of the 10 largest banks in the country is marketing a new AI-based system aimed at flagging upcoming medical claims that are likely to court rejection by payers.
Using CT scans, a deep learning algorithm can recommend optimal lung cancer screening intervals by distinguishing between high-risk and low-risk lung nodules.
The state of California and Civica Rx have penned a 10-year deal to deliver insulin at a reduced rate. The medicines will be available in vials and prefilled pens under the CalRx label.
The 211-year-old New England Journal of Medicine has birthed an online-only monthly journal that will take on “some of the most pressing questions in medicine through the application of AI in the clinic.”